Literature DB >> 29803177

miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway.

Wei Jin1, Fangjie Chen2, Kefeng Wang1, Yan Song1, Xiang Fei1, Bin Wu3.   

Abstract

BACKGROUND: To determine whether and how miR15a/16 regulate TGF-β signaling pathways during the progression of prostate cancer.
METHODS: We used bioinformatics prediction, reporter gene assay, real-time PCR, Matrigel invasion assay and Western blot to dissect the molecular mechanism of how miR-15a/miR-16 may cause metastasis in prostate tumor.
RESULTS: MiR-15a/16 targeted and inhibited the expression of endogenous Smad3 and ACVR2A proteins. The overexpression of miR15a/16 down-regulated p-smad3 expression, affected the expression of both MMP2 and E-cadherin, and down-regulated the expression of the EMT-mediated factors Snail and Twist in LNCaP prostate cancer cells. The overexpression of miR15a/16 decreased the invasion of LNCaP cells. MiR-15a/miR-16 cluster could reverse the invasion of activin A-mediated prostate cancer cells. After the inhibition of the activin/smad signaling pathway, the inhibitory effect of invasion in prostate cancer cells by miR-15a/miR-16 cluster disappeared.
CONCLUSION: Our data indicated that miR15a/16 inhibited the components of TGF-β signaling pathways in LNCaP cell line, which might relate to the progression and metastasis of prostate cancer.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  LNCaP cells; MicroRNAs; TGF-β signaling pathways; miR15a/16

Mesh:

Substances:

Year:  2018        PMID: 29803177     DOI: 10.1016/j.biopha.2018.05.041

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  24 in total

1.  Silencing miRNA-1297 suppresses the invasion and migration of prostate cancer cells via targeting modulation of PTEN and blocking of the AKT/ERK pathway.

Authors:  Lei Wang; Jing Gao; Yu Zhang; Shaosan Kang
Journal:  Exp Ther Med       Date:  2021-05-17       Impact factor: 2.447

2.  MicroRNA-15a promotes prostate cancer cell ferroptosis by inhibiting GPX4 expression.

Authors:  Po Xu; Ying Wang; Zhe Deng; Zhibo Tan; Xiaojuan Pei
Journal:  Oncol Lett       Date:  2022-01-03       Impact factor: 2.967

Review 3.  Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers.

Authors:  Wei Jin; Xiang Fei; Xia Wang; Yan Song; Fangjie Chen
Journal:  Mediators Inflamm       Date:  2020-05-04       Impact factor: 4.711

4.  MicroRNA‑16 inhibits endometrial stromal cell migration and invasion through suppression of the inhibitor of nuclear factor‑κB kinase subunit β/nuclear factor‑κB pathway.

Authors:  Xiaoping Wang; Rui Ren; Meili Shao; Jun Lan
Journal:  Int J Mol Med       Date:  2020-05-29       Impact factor: 4.101

5.  Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p.

Authors:  Huijuan Wu; Xin Tian; Chaoyang Zhu
Journal:  Cancer Cell Int       Date:  2020-07-02       Impact factor: 5.722

Review 6.  Contributions of Thyroid Hormone to Cancer Metastasis.

Authors:  Shaker A Mousa; Gennadi V Glinsky; Hung-Yun Lin; Osnat Ashur-Fabian; Aleck Hercbergs; Kelly A Keating; Paul J Davis
Journal:  Biomedicines       Date:  2018-08-22

7.  Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.

Authors:  Xiao-Hong Yin; Ying-Hui Jin; Yue Cao; York Wong; Hong Weng; Chao Sun; Jun-Hao Deng; Xian-Tao Zeng
Journal:  Front Oncol       Date:  2019-08-07       Impact factor: 6.244

8.  MicroRNA-215-3p Suppresses the Growth, Migration, and Invasion of Colorectal Cancer by Targeting FOXM1.

Authors:  Xiaowei Tang; Xianfeng Shi; Nianfei Wang; Wanren Peng; Zhendong Cheng
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

9.  Upregulation Of miR-149-3p Suppresses Spinal Chordoma Malignancy By Targeting Smad3.

Authors:  Jie Yao; Xuejian Wu
Journal:  Onco Targets Ther       Date:  2019-11-19       Impact factor: 4.147

Review 10.  Small RNAs, Big Diseases.

Authors:  Iwona Rzeszutek; Aditi Singh
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.